D-0025-2025 Class II Ongoing
FDA drug recall D-0025-2025 was initiated by Akron Pharma, Inc. on Oct 15, 2024 and is designated Class II. Reason for recall: CGMP Deviations The recall status is ongoing. Affected quantity: 10845 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 30, 2024
- Initiation Date
- Oct 15, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 10845 bottles
Product description
OneLAX Docusate Sodium Liquid (docusate sodium 50 mg/5 mL) Stool Softener Laxative, 16 FL OZ (473 mL) bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc., Fairfield, NJ 07004, NDC 71399-0039-06.
Reason for recall
CGMP Deviations
Distribution pattern
Nationwide in the US
Code information
Lot #ODS230001A, ODS230002A, Exp. 10/2025; ODS230003A, Exp. 11/2025.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0025-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026